All the three treatments evaluated largely meet WHO criteria (at least 95% efficacy). AS–AQ and AL–LM may continue to be used and DHA–PPQ may be also recommended as first-line treatment for uncomplicated falciparum malaria in Maradi.
Malaria Journal 2018 17:52, 25 January 2018
Malaria Journal 2017 16:62, 2 February 2017
No evidence was found to corroborate the specific allegation of artemisinin resistance in Lunda Sul.